AKANDA CORP.(AKAN)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $2.6M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
AKAN Stock Analysis & AI Quality Score
AI stock analysis and institutional research for AKANDA CORP. (AKAN), a Healthcare sector company. AKAN is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $2.6m in revenue. Based on the latest XBRL financial filings (FY 2024), AKANDA CORP. reports quarterly revenue of $836.7K, net income of $-4.1M. Top institutional holders of AKAN by reported 13-F value include CONTINUUM WEALTH ADVISORS,, XTX Topco Ltd, UBS Group AG, based on the most recent SEC filings. AKAN trades on the Nasdaq exchange and files with the SEC under CIK 1888014. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AKAN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AKANDA CORP. directly from SEC EDGAR.
Revenue
FY 2024
$836.7K
Net Income
FY 2024
$-4.1M
AI Insight: AKAN Financial Trends
Insufficient financial data to assess trends; all metric fields are missing across the reported periods.
• No revenue, net income, operating income, cash flow, debt, or equity figures available for any quarter.
⚠ Complete absence of disclosed financials prevents trend analysis and risk assessment.
AI Insight: AKAN Ratio Trends
Insufficient data to assess trends — all key profitability and return metrics are missing across the entire dataset.
• No operating margin, net profit margin, ROE, ROA, ROIC, or leverage data available for any period Q4 2021–Q2 2025.
⚠ Complete absence of financial metrics prevents assessment of operational efficiency, profitability direction, or capital structure changes.
Get alerted when AKAN's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for AKANDA CORP. including:
Top Institutional Holders of AKAN
CONTINUUM WEALTH ADVISORS, LLC
$11.7K16,723 shXTX Topco Ltd
$8.0K11,417 shUBS Group AG
$1.6K2,274 shHRT FINANCIAL LP
$10.0015,641 shSBI Securities Co., Ltd.
$7.0010 shVision Retirement, LLC
$6.008 sh
| Fund | Value | Shares |
|---|---|---|
| CONTINUUM WEALTH ADVISORS, LLC | $11.7K | 16,723 |
| XTX Topco Ltd | $8.0K | 11,417 |
| UBS Group AG | $1.6K | 2,274 |
| HRT FINANCIAL LP | $10.00 | 15,641 |
| SBI Securities Co., Ltd. | $7.00 | 10 |
| Vision Retirement, LLC | $6.00 | 8 |
More Healthcare Companies
View all Healthcare →Put AKAN on your watchlist
Track score changes the day AKANDA CORP. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is AKAN a good stock to buy?
13F Pro's AI-powered analysis of AKANDA CORP. (AKAN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AKAN are available on the AKAN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own AKAN?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AKAN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of AKANDA CORP.'s investment landscape.